Fiche centre
Cmax Clinical Research
Adelaide — Australia
Essais liés3clinical trials
VilleAdelaidelocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06205628
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PRO-1562 Oral Capsules | SEP | Phase 1/2 | NCT07826689 | A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis | NOT_YET_RECRUITING |
| ADX-850 | Hypertension | Phase 1 | NCT06205628 | Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension | ACTIVE_NOT_RECRUITING |
| Lucid-MS (Lucid-21-302) | SEP | Phase 1 | NCT06595706 | Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants | COMPLETED |